[go: up one dir, main page]

KR920012110A - 산화형 글루타티온 알킬 에스테르 - Google Patents

산화형 글루타티온 알킬 에스테르 Download PDF

Info

Publication number
KR920012110A
KR920012110A KR1019910024588A KR910024588A KR920012110A KR 920012110 A KR920012110 A KR 920012110A KR 1019910024588 A KR1019910024588 A KR 1019910024588A KR 910024588 A KR910024588 A KR 910024588A KR 920012110 A KR920012110 A KR 920012110A
Authority
KR
South Korea
Prior art keywords
formula
alkyl ester
oxidized glutathione
pharmaceutically acceptable
alkyl group
Prior art date
Application number
KR1019910024588A
Other languages
English (en)
Other versions
KR0178794B1 (ko
Inventor
가즈미 오가다
다까히로 사까가미
유우이찌 이소와끼
히데끼 쓰루오까
Original Assignee
요시다 쇼오지
센쥬 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시다 쇼오지, 센쥬 세이야꾸 가부시끼가이샤 filed Critical 요시다 쇼오지
Publication of KR920012110A publication Critical patent/KR920012110A/ko
Application granted granted Critical
Publication of KR0178794B1 publication Critical patent/KR0178794B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

내용 없음

Description

산화형 글루타티온 알킬 에스테르
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 본 발명에 관한 산화형 글루타티온 이소프로필 에스테르의 IR스펙트럼을 나타낸다.

Claims (5)

  1. 식(I):
    (식중, R은 저급 알킬기를 나타낸다)로 표시되는 산화형 글루타티온 알킬 에스테르 또는 그것의 약학적 허용염.
  2. 식(II):
    (식중, R은 저급 알킬기를 나타낸다)로 표시되는 환원형 글루타티온 모노알킬 에스테르를 물 또는 수용액에 공기, 과산화수소 또는 요오드로 산화시키는 것을 특징으로 하는 제1항의 산화형 글루타티온 알킬 에스테르의 제조방법.
  3. 식(I):
    (식중, R은 저급 알킬기를 나타낸다)로 표시되는 산화형 글루타티온 알킬 에스테르 또는 이것의 약학적 허용염을 약학적 허용 담체와 함께 혼합한 혼합물로서 함유하는 약학적 조성물.
  4. 제3항에 있어서, 정제, 과립, 파우더, 캡슐 또는 주사액 형태인 것을 특징으로 하는 약학적 조성물.
  5. 식(I):
    (식중, R은 저급 알킬기를 나타낸다)로 표시되는 산화형 글루타티온 알킬 에스테르 또는 이것의 약학적 허용염의 약리학적 유효량을 경우 또는 비경구 투여하는 것으로 이루어지는, 동물의 급성 또는 만성 간질환의 예방 및 치료방법.
    ※ 참고사항; 최초출원 내용에 의하여 공개되는 것임.
KR1019910024588A 1990-12-28 1991-12-27 산화형 글루타티온 알킬 에스테르 KR0178794B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2416855A JP2921124B2 (ja) 1990-12-28 1990-12-28 酸化型グルタチオンアルキルエステル
JP90-416855 1990-12-28

Publications (2)

Publication Number Publication Date
KR920012110A true KR920012110A (ko) 1992-07-25
KR0178794B1 KR0178794B1 (ko) 1999-04-01

Family

ID=18525041

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910024588A KR0178794B1 (ko) 1990-12-28 1991-12-27 산화형 글루타티온 알킬 에스테르

Country Status (9)

Country Link
US (1) US5223488A (ko)
EP (1) EP0497001B1 (ko)
JP (1) JP2921124B2 (ko)
KR (1) KR0178794B1 (ko)
AT (1) ATE150764T1 (ko)
CA (1) CA2057734C (ko)
DE (1) DE69125360T2 (ko)
ES (1) ES2099125T3 (ko)
RU (1) RU2043994C1 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09124509A (ja) * 1995-10-27 1997-05-13 Sumitomo Electric Ind Ltd 肝炎治療剤
US6251857B1 (en) * 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
AU1113097A (en) * 1995-12-14 1997-07-03 Mark Borisovich Balazovsky Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
AU3308899A (en) 1998-02-24 1999-09-06 Dovetail Technologies, Inc. Small molecules that elicit a polarized th1 response and for modulation of cellular immunity
US20070142267A1 (en) 1998-11-23 2007-06-21 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
US7172905B2 (en) 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
EP1521961A2 (en) * 2002-07-05 2005-04-13 The University of Chicago Characterization of biochips containing self-assembled monolayers with maldi-tof-ms
US7080671B2 (en) * 2002-12-17 2006-07-25 Paraphase, Inc. Replacement vehicle fuel intake device
US6941707B2 (en) * 2003-05-02 2005-09-13 Certainteed Corporation Vented soffit panel
US20110064828A1 (en) * 2009-09-11 2011-03-17 Novelos Therapeutics, Incorporated Treatment of metastatic tumors and other conditions
US20130245199A1 (en) 2012-03-14 2013-09-19 Ralf Mruk Functionalized elastomer
US20130245198A1 (en) 2012-03-14 2013-09-19 Ralf Mruk Pneumatic tire
RU2692065C1 (ru) * 2018-04-05 2019-06-20 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Глутатионаммониевые соли o,o-диорганилдитиофосфорных кислот, обладающие антиоксидантной и противоопухолевой активностью

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879370A (en) * 1983-12-02 1989-11-07 Cornell Research Foundation, Inc. Glutathione delivery system
FR2579461B1 (fr) * 1985-03-28 1988-08-26 Strasbourg Universite L Pasteu Amides de l'acide para-methoxycinnamique et de l'acide urocanique utilises comme filtres solaires; procedes d'obtention, compositions dermo-pharmaceutiques et cosmetiques les contenant et applications
JPH075631B2 (ja) * 1986-03-19 1995-01-25 参天製薬株式会社 グルタチオン誘導体

Also Published As

Publication number Publication date
EP0497001B1 (en) 1997-03-26
EP0497001A2 (en) 1992-08-05
ES2099125T3 (es) 1997-05-16
RU2043994C1 (ru) 1995-09-20
EP0497001A3 (en) 1993-06-23
DE69125360D1 (de) 1997-04-30
DE69125360T2 (de) 1997-10-23
CA2057734C (en) 1997-12-02
JPH04230698A (ja) 1992-08-19
KR0178794B1 (ko) 1999-04-01
JP2921124B2 (ja) 1999-07-19
US5223488A (en) 1993-06-29
CA2057734A1 (en) 1992-06-29
ATE150764T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
KR920012110A (ko) 산화형 글루타티온 알킬 에스테르
KR900006318A (ko) 피페리디닐 벤즈이미다졸
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
KR890701562A (ko) 면역조절 아자스 피란류
KR850000975A (ko) 발프로익산과 그 염의 혼합물을 토대로 한 조성물
KR870003974A (ko) 비시클로 치환된 페닐아세토니트릴 유도체
KR960007592A (ko) 신규한 피롤로카바졸
KR950000663A (ko) 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질
KR890003391A (ko) 칼슘 보충제
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
KR890005088A (ko) 4- 아미노피리딘 유도체 및 그의 산 부가염
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
KR920017669A (ko) 갈륨 화합물
KR910002437A (ko) 항염증성 조성물, 항알레르기성 조성물 또는 이들 혼합성질의 조성물
KR920019350A (ko) 자기면역질환요법을 위한 약제조성물
KR900003177A (ko) 테트라시클릭계 우울증 치료제
KR890006639A (ko) 벤조티아진 디옥사이드 유도체
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR900003174A (ko) 벤조푸로[3,2-c] 퀴놀린 화합물
KR930012018A (ko) 약제학적 조성물
KR900012925A (ko) 인돌 유도체
JPS5489036A (en) Remedy and preventive for hypersensitivity to light
KR920005986A (ko) 혈소판 응집 억제용 약제학적 조성물
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
KR890012960A (ko) 결정성 β-락탐 용매화물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19911227

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19960201

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19911227

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19980630

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19980929

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19981125

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19981125

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction

Patent event code: PG17011E01I

Patent event date: 19990602

Comment text: Request for Publication of Correction

Publication date: 19990701

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20020813